Abstract
Revolutionary new opportunities to study human disease were heralded by the development of two new cell-based techniques. These are the methods able to obtain normal development after somatic cell nuclear transfer (SCNT) [45] and to derive stem cells from human embryos [38]. Use of these two new techniques together will provide opportunities to study inherited human disease that are not available in any other way. Such cells would provide new opportunities to study the pathophysiology of inherited human diseases and in turn make it possible to use high-throughput screens to identify drugs able to prevent symptoms of the disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
